Skip to main content
15 search results for:

Oligometastases 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 07-09-2021 | Oligometastases | News | Article

    Single-fraction SABR may be preferred for lung oligometastases

    Stereotactic ablative body radiotherapy offers similar outcomes, in terms of toxicity and efficacy, whether it is given as a single fraction or in multiple fractions to patients with up to three lung oligometastases, SAFRON II trial data show.

  2. 22-12-2020 | Oligometastases | News | Article

    SBRT favorable for extracranial oligometastases

    Patients with extracranial oligometastases derive a long-term survival benefit from stereotactic body radiotherapy, research suggests.

  3. 14-01-2021 | Oligometastases | News | Article

    Real-world data support efficacy of SABR for extracranial oligometastases

    The beneficial survival outcomes and low toxicity associated with stereotactic ablative body radiotherapy in patients with extracranial oligometastases persist in the real-world setting.

  4. 14-01-2021 | Oligometastases | Highlight | Teaser
    medwireNews top story

    Real-world data support efficacy of SABR for extracranial oligometastases

    The beneficial survival outcomes and low toxicity associated with stereotactic ablative body radiotherapy in patients with extracranial oligometastases persist in the real-world setting.

  5. 06-10-2023 | Prostate cancer | News | Article

    Add-on SBRT improves outcomes of men with oligometastatic CRPC

    Patients with oligometastatic castration-resistant prostate cancer benefit from the addition of stereotactic body radiotherapy to first-line abiraterone acetate plus prednisone.

  6. 23-01-2023 | Non-small-cell lung cancer | News | Article
    guidelinesWatch

    ESMO releases guideline for metastatic NSCLC without oncogenic drivers

    The authors also provide guidance for treating special populations, such as older patients and those with oligometastases.

  7. 02-11-2021 | Renal cell carcinoma | News | Article

    Radiotherapy without systemic therapy feasible for oligometastatic RCC

    Definitive radiotherapy without systemic therapy may be a feasible strategy for the treatment of oligometastatic renal cell carcinoma, phase 2 study findings indicate.

  8. play
    14-02-2021 | ASCO GU 2021 | Conference coverage | Video

    Pembrolizumab, SABR develop a RAPPORT for oligometastatic RCC

    Shankar Siva provides an overview of the RAPPORT study of pembrolizumab plus stereotactic ablative body radiotherapy for the treatment of renal cell carcinoma with oligometastases.

  9. 26-11-2020 | Oligometastases | News | Article

    Oligometastatic cancer outcomes acceptable with SABR

    Stereotactic ablative radiotherapy is associated with “clinically acceptable” rates of toxicity, local control, progression-free survival, and overall survival in people with oligometastatic cancer, meta-analysis data suggest.

  10. 02-04-2020 | Castration-sensitive prostate cancer | News | Article

    SABR benefits men with oligometastatic prostate cancer

    Stereotactic ablative radiotherapy is associated with a significantly lower risk for disease progression at 6 months relative to observation in men with oligometastatic prostate cancer, phase 2 study data show.

  11. play
    15-02-2020 | ASCO GU 2020 | Conference coverage | Video

    Expert comment: The CARD, TITAN, and STOMP trials

    ASCO expert Robert Dreicer shares his views on the updates from the CARD, TITAN, and STOMP prostate cancer trials presented at ASCO GU 2020 (3:07). Read more about the STOMP trial and the CARD trial

  12. 14-02-2020 | ASCO GU 2020 | News | Article

    ​​​​​​​STOMP 5-year results confirm potential of metastasis-directed therapy in prostate cancer

    Metastasis-directed therapy for oligometastatic recurrent prostate cancer continues to be associated with better androgen deprivation therapy-free survival relative to surveillance at 5 years, show follow-up findings from the STOMP trial.

  13. 23-04-2019 | Oligometastases | News | Article

    SABR may improve survival in oligometastatic cancer

    The phase II SABR-COMET study has indicated that stereotactic ablative radiotherapy prolongs overall and progression-free survival versus palliative treatment in patients with up to five oligometastases.

  14. 22-07-2019 | Non-small-cell lung cancer | News | Article

    Local ablative therapy–pembrolizumab benefit suggested for metastatic NSCLC

    Data from two phase II studies published in JAMA Oncology lend support to the sequential use of local ablative therapy and PD-1 blockade in patients with metastatic non-small-cell lung cancer.

  15. 13-05-2019 | Non-small-cell lung cancer | News | Article

    Local consolidative therapy improves oligometastatic NSCLC survival

    Patients with stage IV non-small-cell lung cancer and no more than three metastases derive an overall survival benefit from aggressive local consolidative therapy, suggest trial results.

  • 1

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.